Pulsion Medical Systems SE / Key word(s): Change in Forecast 02.11.2012 10:21 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Pulsion increases Guidance for FY 2012 In the first 9 months of the current Fiscal Year 2012 Pulsion Medical Systems SE, Feldkirchen, was able to increase its EBIT by 34,4% to EUR 7,0 Mio. compared to the previous year's time period. In the same period revenue growth was 5,3%. As of October 31st, 2012 revenue growth stood at 6,3%. In the first three quarters Free Cash Flow increased by 73% to EUR 6,0 Mio. On 30th of September. Net Liquidity amounted to 11,6 Mio. Regarding full-year 2012, Pulsion is giving the following guidance: a- Revenues EUR 34,0 - 34,7 Mio (2011: EUR 32,9 Mio) b- EBITDA: EUR 10,7 - 11,5 Mio. (2011: EUR 8,7 Mio) c- EBIT: EUR 8,6 - 9,4 Mio. (2011: EUR 6,8 Mio) d- Revenue per Share (diluted): 70-76 cents (2011: 51 cents) The publication of the interim report for the third quarter is planned for the 14th of November 2012 before the opening of XETRA. Contact: Investor Relations PULSION Medical Systems SE Ralph Schäfer Director Legal Affairs Tel.: +49 (0)89 / 459914 211 Fax: +49 (0)89 / 459914 481 E-mail: schaefer@pulsion.com 02.11.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Pulsion Medical Systems SE Hans- Riedl- StraÃe 21 85622 Feldkirchen Germany Phone: +49 (0)89 4599 14-0 Fax: +49 (0)89 4599 14-18 E-mail: info@pulsion.com Internet: www.pulsion.com ISIN: DE0005487904 WKN: 548790 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Pulsion Medical Systems SE increases Guidance for FY 2012
| Source: EQS Group AG